Syndax Pharmaceuticals Stock In The News
| SNDX Stock | USD 12.95 0.15 1.15% |
Our overall analysis of Syndax Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Syndax Pharmaceuticals. The specific impact of Syndax Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Syndax Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Syndax Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Syndax Pharmaceuticals Backtesting and Syndax Pharmaceuticals Hype Analysis. For more information on how to buy Syndax Stock please use our How to Invest in Syndax Pharmaceuticals guide.
Syndax |
Syndax Pharmaceuticals Today Top News and Investor Outlook
Syndax Pharmaceuticals Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Syndax and other traded companies coverage with news coverage. We help investors stay connected with Syndax headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Syndax Stock performance. Please note that trading solely based on the Syndax Pharmaceuticals hype is not for everyone as timely availability and quick action are needed to avoid losses.
Syndax Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Syndax earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Syndax Pharmaceuticals that are available to investors today. That information is available publicly through Syndax media outlets and privately through word of mouth or via Syndax internal channels. However, regardless of the origin, that massive amount of Syndax data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Syndax Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Syndax Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Syndax Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Syndax Pharmaceuticals alpha.
Syndax Largest EPS Surprises
Earnings surprises can significantly impact Syndax Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-03-08 | 2020-12-31 | -0.49 | -0.44 | 0.05 | 10 | ||
2019-11-07 | 2019-09-30 | -0.47 | -0.41 | 0.06 | 12 | ||
2016-08-09 | 2016-06-30 | -0.53 | -0.47 | 0.06 | 11 | ||
2018-11-05 | 2018-09-30 | -0.76 | -0.68 | 0.08 | 10 | ||
2016-11-10 | 2016-09-30 | -0.76 | -0.84 | -0.08 | 10 | ||
2023-08-03 | 2023-06-30 | -0.73 | -0.64 | 0.09 | 12 |
Syndax Pharmaceuticals Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Syndax Pharmaceuticals Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
12th of March 2025
Syndax Pharmaceuticals SWOT analysis stock soars on FDA approvals, faces profitability hur... at news.google.com
5th of March 2025
Q4 2024 Syndax Pharmaceuticals Inc Earnings Call Transcript at gurufocus.com
4th of March 2025
Syndax Pharmaceuticals, Inc. Q4 2024 Earnings Call Transcript at insidermonkey.com
3rd of March 2025
Syndax Pharmaceuticals misses Q4 estimates initiates Q1 and FY25 outlook at seekingalpha.com
28th of February 2025
Earnings To Watch Syndax Pharmaceuticals Inc Reports Q4 2024 Result at gurufocus.com
25th of February 2025
Syndax Pharmaceuticals Inc Announces Upcoming Financial Results and Business Update at gurufocus.com
24th of February 2025
Syndax to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference... at globenewswire.com
10th of February 2025
INCYs Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales at finance.yahoo.com
13th of January 2025
Syndax Pharmaceuticals Inc Announces Key Milestones and Future Plans at J.P. ... at gurufocus.com
Syndax Pharmaceuticals Investors Sentiment
The influence of Syndax Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Syndax. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Syndax Pharmaceuticals' public news can be used to forecast risks associated with an investment in Syndax. The trend in average sentiment can be used to explain how an investor holding Syndax can time the market purely based on public headlines and social activities around Syndax Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Syndax Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Syndax Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Syndax Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Syndax Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Syndax Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Syndax Pharmaceuticals' short interest history, or implied volatility extrapolated from Syndax Pharmaceuticals options trading.
Additional Tools for Syndax Stock Analysis
When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.